cbdMD (YCBD) Cash from Discontinued Operations (2019 - 2021)
cbdMD (YCBD) reported Cash from Discontinued Operations of 7500.0 for Q3 2021, down 97.04% on a YoY basis from 253750.0 in Q3 2020, and up 100.0% sequentially from 3750.0 in Q2 2021.
cbdMD (YCBD) Cash from Discontinued Operations (2019 - 2021) Analysis & Trends
cbdMD (YCBD) has 3 years of Cash from Discontinued Operations data on file, last reported at 7500.0 in Q3 2021.
- For the quarter ending Q3 2021, Cash from Discontinued Operations fell 97.04% year-over-year to 7500.0; the trailing twelve-month figure through Sep 2021 stood at 436167.0 (down 25.71% YoY), and the FY2021 full-year result was 436167.0, down 25.71% from the prior year.
- Cash from Discontinued Operations grew to 7500.0 in Q3 2021, from 3750.0 in the prior quarter.
- In the past five years, Cash from Discontinued Operations ranged from a high of 422417.0 in Q4 2020 to a low of 2500.0 in Q1 2021.
- A 3-year average of 127906.25 and a median of 83333.0 in 2020 frame the typical range for Cash from Discontinued Operations.
- Across the five-year window, Cash from Discontinued Operations surged 153.45% in 2020 and tumbled 97.04% in 2021, its largest moves.
- Tracing YCBD's Cash from Discontinued Operations over 3 years: stood at 166667.0 in 2019, then soared by 153.45% to 422417.0 in 2020, then plunged by 98.22% to 7500.0 in 2021.
- Business Quant data shows YCBD's Cash from Discontinued Operations at 7500.0 in Q3 2021, 3750.0 in Q2 2021, and 2500.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.46 Bn | 87.60 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.93 Bn | 32.19 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.54 Bn | 30.60 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.49 Bn | 23.43 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.05 Bn | 20.89 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.24 Bn | 18.43 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.45 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.60 Bn | 12.17 Bn | 785.00 Mn | - |
| 10 | cbdMD | 4.57 Mn | 1.18 Mn | 3.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 7,500.00 |
| Sep 30, 2021 | 7,500.00 |
| Jun 30, 2021 | 3,750.00 |
| Jun 30, 2021 | 3,750.00 |
| Mar 31, 2021 | 2,500.00 |
| Mar 31, 2021 | 2,500.00 |
| Dec 31, 2020 | 422,417.00 |
| Dec 31, 2020 | 422,417.00 |
| Sep 30, 2020 | 253,750.00 |
| Sep 30, 2020 | 253,750.00 |
| Jun 30, 2020 | 83,333.00 |
| Jun 30, 2020 | 83,333.00 |
| Mar 31, 2020 | 83,333.00 |
| Mar 31, 2020 | 83,333.00 |
| Dec 31, 2019 | 166,667.00 |
| Dec 31, 2019 | 166,667.00 |